SMTL ID : 3ezr.1

CDK-2 with indazole inhibitor 17 bound at its active site

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

2 x EZR: 3-methoxy-4-{3-[4-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-indazol-6-yl}aniline(Non-covalent)

EZR.1: 16 residues within 4Å: Chain A: I.12, A.33, K.35, V.66, F.82, E.83, F.84, L.85, H.86, D.88, K.91, Q.133, L.136, A.146, D.147, F.148 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:I.12, A:A.33, A:F.82, A:L.136, A:A.146 Hydrogen bonds: A:E.83, A:L.85, A:L.85, A:F.148, A:F.148 Salt bridges: A:D.88 pi-Stacking: A:F.82 EZR.2: 3 residues within 4Å: Chain A: L.27, T.28, E.30 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:T.28

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Trujillo, J.I. et al., 2-(6-Phenyl-1H-indazol-3-yl)-1H-benzo[d]imidazoles: Design and synthesis of a potent and isoform selective PKC-zeta inhibitor. Bioorg.Med.Chem.Lett. (2009)

Release Date

2009-02-03

Peptides

Cell division protein kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cell division protein kinase 2

Related Entries With Identical Sequence